Home     l    Contact us    l   Therapy Center   l   Press Coverage     l    Disclamer   l     Copyright
Aternative Treatment of Ulcerative colitis,cure of ulcerative colitis,Colitis treatment,ulcerative treatment,treatment of ulcer,alternative treatment,alternative to homeopathy treatment,Ayurvedic treatment,ayurveda treatment,Herbs treatment,Indian Treatment,Online treatment
About Ulcerative Colitis  |   Our Treatment   |   Order Now   |   Diet   |   Case Studies   |   Patient's History    
Dr. Harish Verma

 
 

CALL US AT

Cell  +91 9910034500


Tel +91+11-22050506


Fax +91+11-22050504

Ulcerin Compound I & II
 can be  obtained from

Sushruta
Ayurvedic Therapy Center


E-54,1st Floor, Vikas Marg,
Laxmi Nagar, New Delhi-92
Tel +91+11-22050127,
Fax +91+11-22050504
E-mail.-
sushruta@bol.net.in


Alternative treatment,ulcerative colitis,alternative treatment of colitis,colitis treatment,ayurvedic treatment,ayurveda treatment,Treatment of ulcer,treatment of ibd,our treatment,Modern treatment

Introduction of Treatment

Our Ayurveda based treatment provided relief to patients with severe disease and those patients who never had a remission with mainline allopathic drugs were saved from surgery with the help of this treatment.

Our treatment is composed of

Ulcerin Compound I & Ulcerin Compound II.

A study on role of Ulcerin Compound I & II in Ulcerative Colitis

Because the condition of many patients is not adequately controlled by 5-aminosalicylic acid, 5-ASA, and mesalazine (Brands-Asacol; Mesasal; Pentasa; Salofalk) and steroid therapy, doctors and researchers worldwide are looking for a breakthrough in the treatment of Ulcerative Colitis.
Ten years back the study was initiated by myself at Sushruta Ayurvedic Therapy Centre New Delhi and Chandigarh in order to find out whether the Ulcerin Compound I & Ulcerin Compound II:

  • Encourages fast remission of symptoms and
  • Prevents relapse, which is common feature of Ulcerative Colitis

In ten years, I have treated approximately five thousand patients of Ulcerative Colitis with these compounds. All patients of resistant as well as continuous Ulcerative Colitis took Ulcerin Compound I & Ulcerin Compound II along with their main medication. Within three to four weeks, their symptoms were controlled after which they underwent a gradual tapering of allopathic drugs they had been using.

The results of my treatment were assessed on the basis on symptomatic relief only. After treatment only a few patients could be subjected to investigations like colonoscopic or Sigmoidoscopic and Histopathological examination due to the lack of facilities in my center.

Approximately 85% patients, who never had a remission with 5-aminosalicylic acid, 5-ASA, and mesalazine (Brands-Asacol; Mesasal; Pentasa; Salofalk) and steroid therapy, became symptoms free with the addition of these compounds. Many patients were thinking of surgery, because they were advised Colectomy (total removal of large intestines) before my treatment. Many (approx. 85%) patients went in remission. This success gave me lot of satisfaction in my life.

However there were relapses of the disease in about 50% of patients in my follow up study of about five to ten years, but the advantage was that in most of relapsed cases the symptoms were not so severe as in the past.

I have complete clinical data of my patients with me. I wish that the results of my treatment should be evaluated by proper scientific methods. I invite the research organizations or pharmaceutical companies, interested to carry on further research on Ulcerin Compound I & Ulcerin Compound II.

Group 1 Resistant Ulcerative Colitis

Total Cases

Improved

Not Relieved

Relapsed in 2 years

80

60

20

30

Group 2 Continuous Ulcerative Colitis

Total Cases

Improved

Not Relieved

Relapsed in 2 years

60

40

20

20

Group 3 Relapsing Ulcerative Colitis

Total Cases

Improved

Not Relieved

Relapsed in 2 years

60

50

10

10

 

Caution

Opiates anti- diarrheals such as Karpoor Ras , Karpoorasav, Codeine or Loperamide are generally contraindicated in treatment of Ulcerative Colitis because such agent can precipitate toxic megacolon.

ATTENTION RESEARCHERS:

Results of my treatment were assessed on the basis of symptomatic relief. After treatment only a few patients could be subjected to investigations like Colonoscopic or Sigmoidoscopic and Histopathological examination due to the lack of facilities in the center. I wish that the results of my treatment should be evaluated by proper scientific methods. I invite the research organizations, interested to carry on further research on Bael fruit based Ayurvedic Compounds.

Dr. HARISH KUMAR VERMA

©Sushruta Ayurvedic Therapy Center, E-54, Ist Floor, Vikas Marg, Laxmi Nagar, Delhi-110092,India